Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masato Tohyama is active.

Publication


Featured researches published by Masato Tohyama.


Clinical and Experimental Immunology | 1996

IL‐12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans

Kazuyoshi Kawakami; Masato Tohyama; Qifeng Xie; Atsushi Saito

We examined the role of IL‐12 in host resistance to Cryptococcus neoformans using a murine model of pulmonary and disseminated infection. In this model, mice were infected intratracheally with viable yeast cells. Mice untreated with IL‐12 allowed an uncontrolled multiplication of yeast cells in the lung with infiltrations of few inflammatory cells, and a cryptococcal dissemination to the brain and meningitis by 3 weeks, resulting in death of all animals within 4–6 weeks. IL‐12, when administered from the day of tracheal infection for 7 days, induced a marked infiltration of inflammatory cells, consisting mostly of mononuclear cells, and significantly reduced the number of viable yeast cells in the lung. The treatment suppressed brain dissemination, as shown by a marked reduction of yeast cells in the brain and prevention of meningitis. These effects resulted in a significant increase in the survival rate of infected mice. In contrast, late administration of IL‐12 commencing on day 7 after instillation of yeast cells failed to protect the mice against infection with C. neoformans. In further experiments, early administration of IL‐12 markedly induced interferon‐gamma (IFN‐γ) mRNA in the lungs of infected mice, while no IFN‐γ mRNA was detected without this treatment. Our results indicate that IL‐12 is effective when administered in the early period of pulmonary cryptococcal infection.


Clinical and Experimental Immunology | 1996

Contribution of tumour necrosis factor-alpha (TNF-α) in host defence mechanism against Cryptococcus neoformans

Kazuyoshi Kawakami; X. Qifeng; Masato Tohyama; Mahboob Hossain Qureshi; Atsushi Saito

We investigated the role of TNF‐α in the host defence mechanism against infection with a virulent strain of Cryptococcus neoformans. Administration of exogenous recombinant human TNF‐α significantly prolonged the survival time of mice infected by intratracheal instillation of the organism. Surprisingly, neutralizing MoAb to murine TNF‐α did not shorten their survival time, a finding inconsistent with previous results. To investigate the cause of this inconsistency, we examined the production of TNF‐α in the lungs of infected mice. During the course of cryptococcosis, there was little or no generation of TNF‐α mRNA in the lung. This might be partly due to a direct inhibitory action of the fungal microorganism on TNF‐α production by macrophages. In vitro production of TNF‐α by murine interferon‐gamma (IFN‐γ)‐ and lipopolysaccharide (LPS)‐stimulated macrophages was strongly inhibited by co‐culturing with the whole yeast cells. In contrast, administration of recombinant murine IL‐12 markedly induced TNF‐α production and the neutralizing anti‐TNF‐α MoAb strongly blocked IL‐12‐induced protection of mice against cryptococcal infection. These results indicate that endogenously synthesized TNF‐α has the potential to contribute to the elimination of C. neoformans and partly mediates the protective effect of IL‐12.


Clinical and Experimental Immunology | 2007

Enhancing effect of oxygen radical scavengers on murine macrophage anticryptococcal activity through production of nitric oxide

Masato Tohyama; Kazuyoshi Kawakami; Mitsuhiko Futenma; Atsushi Saito

We examined the roles of reactive nitrogen intermediates (RNI) and reactive oxygen intermediates (ROI) in interferon‐gamma (IFN‐γ)‐induced cryptococcostatic activity of murine peritoneal macrophages using NG‐monomethyl‐L‐arginine (L‐NMMA), a competitive inhibitor of RNI synthesis, and superoxide dismutase (SOD) and catalase, oxygen radical scavengers. IFN‐γ‐activated macrophages produced nitric oxide (NO) in a dose‐dependent manner, as measured by increased nitrite concentration in the culture supernatant. IFN‐γ also enhanced the suppressive effect on cryptococcal growth in a similar dose‐dependent manner. The induction of killing activity and NO production by an optimal dose of IFN‐γ (100 U/ml) was virtually suppressed by 500 μM L‐NMMA. These results confirmed the importance of the RNI‐mediated effector mechanism in anticryptococcal activity of macrophages. SOD and catalase significantly enhanced the cryptococcostatic activity of macrophages induced by a suboptimal dose of IFN‐γ (20 U/ml). The augmenting effect of these reagents was mediated by NO, since they potentiated the production of NO by macrophages and their effects were totally blocked by L‐NMMA. Our results indicate that the IFN‐γ‐induced anticryptococcal activity of macrophages is dependent mostly on RNI, and suggest that the ROI system down‐regulates the effector mechanism for cryptococcostasis by suppressing the RNI system.


Influenza and Other Respiratory Viruses | 2013

Hamman-Rich syndrome revisited: how to avoid misdiagnosis

Jiro Fujita; Masato Tohyama; Shusaku Haranaga; Haley L. Cash; Futoshi Higa; Masao Tateyama

Please cite this paper as: Fujita et al. (2012) Hamman‐Rich syndrome revisited: How to avoid misdiagnosis. Influenza and Other Respiratory Viruses. DOI: 10.1111/j.1750‐2659.2012.00353.x.


Clinical and Experimental Immunology | 2001

FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice

Satomi Yara; Kazuyoshi Kawakami; Norifumi Kudeken; Masato Tohyama; Katsuji Teruya; T. Chinen; A. Awaya; Atsushi Saito


International Journal of Antimicrobial Agents | 2006

In vitro activity of sitafloxacin compared with several fluoroquinolones against Streptococcus anginosus and Streptococcus constellatus

Natsuo Yamamoto; Jiro Fujita; Takashi Shinzato; Futoshi Higa; Masao Tateyama; Masato Tohyama; Isamu Nakasone; Nobuhisa Yamane


Journal of Antimicrobial Chemotherapy | 2005

In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species

Futoshi Higa; Morikazu Akamine; Shusaku Haranaga; Masato Tohyama; Takashi Shinzato; Masao Tateyama; Michio Koide; Atsushi Saito; Jiro Fujita


Journal of Infection and Chemotherapy | 2003

Isolation of Legionella anisa from multiple sites of a hospital water system: The eradication of Legionella contamination

Natsuo Yamamoto; Toru Kubota; Masao Tateyama; Michio Koide; Chikara Nakasone; Masato Tohyama; Takashi Shinzato; Futoshi Higa; Nobuchika Kusano; Kazuyoshi Kawakami; Atsushi Saito


Journal of Infection and Chemotherapy | 2002

Trends in antimicrobial susceptibility of the Streptococcus milleri group

Natsuo Yamamoto; Toru Kubota; Masato Tohyama; Shuzo Kanamori; Takashi Shinzato; Futoshi Higa; Masao Tateyama; Atsushi Saito


The Journal of the Japanese Association for Infectious Diseases | 2001

Clinical and bacteriological features of 12 cases of liver abscess caused by Streptococcus milleri group

Shuzo Kanamori; Takashi Shinzato; Kazumasa Toyoda; Masato Tohyama; Tetsuo Hirata; Hiroki Nakasone; Futoshi Higa; Masao Tateyama; Nobuchika Kusano; Hiroshi Sakugawa; Atsushi Saito

Collaboration


Dive into the Masato Tohyama's collaboration.

Top Co-Authors

Avatar

Atsushi Saito

University of the Ryukyus

View shared research outputs
Top Co-Authors

Avatar

Futoshi Higa

University of the Ryukyus

View shared research outputs
Top Co-Authors

Avatar

Masao Tateyama

University of the Ryukyus

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jiro Fujita

University of the Ryukyus

View shared research outputs
Top Co-Authors

Avatar

Natsuo Yamamoto

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Isamu Nakasone

University of the Ryukyus

View shared research outputs
Top Co-Authors

Avatar

Kazumasa Toyoda

University of the Ryukyus

View shared research outputs
Researchain Logo
Decentralizing Knowledge